Vaccine Development and Approval Process

Antigen selection: Determining pathogen components (like proteins or sugars) that will trigger a strong and lasting immune response.
Vaccine platforms: Choosing the technology, such as weakened or inactivated pathogens, protein subunits, or newer mRNA approaches, to present the antigen to the immune system.
Preliminary testing: Early laboratory research includes in vitro studies and experiments in animal models to assess safety and immune response.

May 29, 2025

Generating full article…

clinical trials public health global collaboration vaccine development regulatory approval

Uncover the deeper story behind the article. Click a backstory to learn more, and then continue deeper to see just how deep this rabbit hole goes.

Discovering backstory…